speb/financial-data huggingface dataset:
Financial ratios for CGEN — annual report dated 2022-12-31
Total revenue: 2130681.8181818184
Gross profit: 1853693.1818181819
Operating income: -10049431.818181818
Net income: -9572159.090909092
Capital expenditures: 137784.0909090909
Operating cash flow: -9691193.181818182
Depreciation & amortization: 136931.81818181818
Net tangible assets: 22068181.818181816
Owner earnings: -9573011.363636365
Return on net tangible assets (%): -43.379248197734306
Buffett classification: The Gruesome
Stock price: 0.72
Shares outstanding: 94584636
Book value: 22068181.818181816
P/B ratio: 3.0859333352008242
Market cap (USD): 68100937.92
Debt to equity: 0.024781153450051496
Current ratio: 7.225857873982717
Quick ratio: 7.225857873982717
Interest coverage ratio: -1310.1481481481483
COGS to revenue (%): 12.999999999999998
R&D to revenue (%): 408.63999999999993
SG&A to revenue (%): 150.01333333333332
Free cash flow (dilution-adjusted): -11059090.90909091
Buyback yield (%): 0
Retained earnings: -129480965.9090909
Receivables turnover: 23.659305993690854
Capitalized R&D asset: 8706818.181818182
ROCI (R&D-adjusted, %): -13.23413489216598
FCF margin (%): -519.0400000000001
Rule of 40 score: -519.0400000000001
Financial ratios for CGEN — annual report dated 2023-12-31
Total revenue: 9242817.67955801
Gross profit: 8689226.519337017
Operating income: -3588950.276243094
Net income: -5180662.983425414
Capital expenditures: 47513.812154696134
Operating cash flow: -9913259.668508288
Depreciation & amortization: 131491.7127071823
Net tangible assets: 18110220.994475137
Owner earnings: -5096685.082872928
Return on net tangible assets (%): -28.142589118198874
Buffett classification: The Gruesome
Stock price: 1.98
Shares outstanding: 94584636
Book value: 18110220.994475134
P/B ratio: 10.340988071715557
Market cap (USD): 187277579.28
Debt to equity: 0.020607391815006336
Current ratio: 4.362255387192569
Quick ratio: 4.362255387192569
COGS to revenue (%): 5.989419887025912
R&D to revenue (%): 103.02758600077706
SG&A to revenue (%): 29.81260647359455
Free cash flow (dilution-adjusted): -10941436.464088397
Buyback yield (%): 0
Retained earnings: -131084806.62983425
Receivables turnover: 0.5456635898104961
Capitalized R&D asset: 15356220.115519838
ROCI (R&D-adjusted, %): -0.3430920343773779
Rosenberg metric: 0.7850782220068618
FCF margin (%): -118.37771601063989
Revenue growth (%): 333.7962430939226
Rule of 40 score: 215.41852708328273
Financial ratios for CGEN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.81
Shares outstanding: 94584636
Market cap (USD): 171198191.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGEN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.53
Shares outstanding: 94584636
Market cap (USD): 144714493.08
Buyback yield (%): 0
Retained earnings: -133906301.36986302
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGEN — annual report dated 2024-12-31
Total revenue: 7633972.602739726
Gross profit: 5461369.863013699
Operating income: -4079726.0273972605
Net income: -3898904.109589041
Capital expenditures: 32054.794520547945
Operating cash flow: 13590136.98630137
Depreciation & amortization: 133150.68493150684
Net tangible assets: 15044931.506849315
Owner earnings: -3797808.2191780824
Return on net tangible assets (%): -25.243107404304915
Buffett classification: The Gruesome
Stock price: 1.53
Shares outstanding: 94584636
Book value: 15044931.506849315
P/B ratio: 9.61882033255636
Market cap (USD): 144714493.08
Debt to equity: 0.05302837163564847
Current ratio: 5.257787698412698
Quick ratio: 5.257787698412698
COGS to revenue (%): 28.459661211599197
R&D to revenue (%): 89.0396210163652
SG&A to revenue (%): 35.94243468274476
Free cash flow (dilution-adjusted): 12729589.04109589
Buyback yield (%): 0
Retained earnings: -133906301.36986302
Receivables turnover: 103.58364312267658
Capitalized R&D asset: 16050687.069552712
ROCI (R&D-adjusted, %): -13.381689216699161
Rosenberg metric: -0.33896614921937845
FCF margin (%): 166.74921045076084
Revenue growth (%): -17.406435273266357
Rule of 40 score: 149.34277517749447
Financial ratios for CGEN — quarterly report dated 2025-03-31
Total revenue: 618970.189701897
Gross profit: -31436.314363143632
Operating income: -2275067.750677507
Net income: -1946070.4607046072
Capital expenditures: 0
Net tangible assets: 15476422.764227642
Owner earnings: -1946070.4607046072
Return on net tangible assets (%): -12.574420396441832
Buffett classification: The Gruesome
Stock price: 1.46
Shares outstanding: 94584636
Book value: 15476422.764227644
P/B ratio: 8.922835119184702
Market cap (USD): 138093568.56
Debt to equity: 0.048522098480072835
Current ratio: 5.091840137188587
Quick ratio: 5.091840137188587
COGS to revenue (%): 105.07880910683012
R&D to revenue (%): 252.75831873905435
SG&A to revenue (%): 109.7197898423818
Buyback yield (%): 0
Receivables turnover: 0.7255400254129605
Capitalized R&D asset: 1564498.64498645
ROCI (R&D-adjusted, %): -4.536217568156344
Rule of 40 score: 0
Financial ratios for CGEN — quarterly report dated 2025-06-30
Total revenue: 370796.4601769911
Gross profit: -120353.98230088495
Operating income: -2486430.6784660765
Net income: -2165781.7109144544
Capital expenditures: 0
Net tangible assets: 14824778.761061946
Owner earnings: -2165781.7109144544
Return on net tangible assets (%): -14.60920089143585
Buffett classification: The Gruesome
Stock price: 1.78
Shares outstanding: 94584636
Book value: 14824778.761061948
P/B ratio: 11.356705876934097
Market cap (USD): 168360652.08
Debt to equity: 0.05909742120343839
Current ratio: 4.743817713647185
Quick ratio: 4.743817713647185
COGS to revenue (%): 132.4582338902148
R&D to revenue (%): 448.7669053301512
SG&A to revenue (%): 189.33969769291966
Buyback yield (%): 0
Receivables turnover: 0.33386454183266934
Capitalized R&D asset: 2712225.891550951
ROCI (R&D-adjusted, %): -6.765248322991366
Rosenberg metric: -0.056834608468779746
Revenue growth (%): -40.09461742324442
Rule of 40 score: -40.09461742324442
Financial ratios for CGEN — quarterly report dated 2025-09-30
Total revenue: 571299.0936555892
Gross profit: 72809.66767371602
Operating income: -2384592.1450151056
Net income: -2108459.2145015104
Capital expenditures: 0
Net tangible assets: 13240483.383685801
Owner earnings: -2108459.2145015104
Return on net tangible assets (%): -15.9243371514626
Buffett classification: The Gruesome
Stock price: 1.47
Shares outstanding: 94584636
Book value: 13240483.383685801
P/B ratio: 10.501082996057134
Market cap (USD): 139039414.92
Debt to equity: 0.06722037146899101
Current ratio: 4.3839668688063895
Quick ratio: 4.3839668688063895
COGS to revenue (%): 87.25542041248016
R&D to revenue (%): 306.7160232681121
SG&A to revenue (%): 123.4267583289265
Buyback yield (%): 0
Receivables turnover: 0.667725988700565
Capitalized R&D asset: 3383438.3194774385
ROCI (R&D-adjusted, %): -8.549296496568612
Rosenberg metric: 0.11608310111928688
Revenue growth (%): 54.07350258492024
Rule of 40 score: 54.07350258492024
Financial ratios for CGEN — quarterly report dated 2025-12-31
Total revenue: 677143.0125786163
Gross profit: -434806.6729559748
Operating income: -2872856.9874213836
Net income: 17875786.163522013
Capital expenditures: 0
Net tangible assets: 32305345.911949683
Owner earnings: 17875786.163522013
Return on net tangible assets (%): 55.33383302021786
Buffett classification: The Gruesome
Stock price: 1.53
P/E ratio: 12.416010144913527
Shares outstanding: 94584636
Book value: 32305345.911949687
P/B ratio: 4.479583455767003
Market cap (USD): 144714493.08
Debt to equity: 0.028813113860470547
Current ratio: 6.558351794417368
Quick ratio: 6.558351794417368
Effective tax rate (%): 0
COGS to revenue (%): 164.21194118214336
R&D to revenue (%): 257.4170786121665
SG&A to revenue (%): 102.63246323883963
Buyback yield (%): 0
Retained earnings: -142583333.3333333
Receivables turnover: 7.324199931972788
Capitalized R&D asset: 3466223.781699816
ROCI (R&D-adjusted, %): -6.248410061593253
Rosenberg metric: -0.28969139439384084
Revenue growth (%): 18.52688374591326
Rule of 40 score: 18.52688374591326
Financial ratios for CGEN — annual report dated 2025-12-31
Total revenue: 731771.4339622642
Gross profit: -434806.6729559748
Operating income: -2872856.9874213836
Net income: 11114150.943396226
Capital expenditures: 95911.9496855346
Operating cash flow: 9947798.742138363
Depreciation & amortization: 149371.06918238994
Net tangible assets: 32305345.911949683
Owner earnings: 11167610.062893081
Return on net tangible assets (%): 34.56892272050307
Buffett classification: The Gruesome
Stock price: 1.53
P/E ratio: 13.0207420987013
Shares outstanding: 94584636
Book value: 32305345.911949687
P/B ratio: 4.479583455767003
Market cap (USD): 144714493.08
Debt to equity: 0.028813113860470547
Current ratio: 6.558351794417368
Quick ratio: 6.558351794417368
Effective tax rate (%): 0.15255530129672007
COGS to revenue (%): 397.5448291420135
R&D to revenue (%): 977.9405120294889
SG&A to revenue (%): 405.2370272196722
Free cash flow (dilution-adjusted): 9260062.893081762
Buyback yield (%): 0
Retained earnings: -142583333.3333333
Receivables turnover: 7.915078775510205
Capitalized R&D asset: 14852928.829859292
ROCI (R&D-adjusted, %): -6.214928562217802
Rosenberg metric: -0.8674342747395933
FCF margin (%): 1265.43104353528
Revenue growth (%): -90.41427744056035
Rule of 40 score: 1175.0167660947195
Financial ratios for CGG.TO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 3679527.559055118
Buffett classification: The Gruesome
Stock price: 2.267716535433071
Shares outstanding: 396413753
Market cap (USD): 898954022.5511811
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGG.TO — annual report dated 2022-12-31
Total revenue: 812462500
Gross profit: 284569852.9411765
Operating income: 229052941.17647058
Net income: 165736029.41176468
Capital expenditures: 33511764.70588235
Operating cash flow: 328881617.6470588
Depreciation & amortization: 152970588.2352941
Net tangible assets: 1385278676.4705882
Owner earnings: 285194852.9411764
Return on net tangible assets (%): 20.587543704043405
Capex to operating income (%): 14.630576029173836
Buffett classification: The Great
Stock price: 2.5955882352941173
P/E ratio: 6.208226884929526
Shares outstanding: 396413753
Book value: 1399580882.352941
P/B ratio: 0.7351678538690679
Market cap (USD): 1028926873.5955881
Debt to equity: 0.4387264044383035
Current ratio: 1.1471998872595457
Quick ratio: 0.6882695123192433
Effective tax rate (%): 18.11460997442455
Interest coverage ratio: 12.268599109920837
COGS to revenue (%): 64.97440153346443
R&D to revenue (%): 2.296124074504796
SG&A to revenue (%): 4.009777826849927
Free cash flow (dilution-adjusted): 295369852.9411765
Buyback yield (%): 0
Retained earnings: 420019117.6470588
Inventory turnover: 2.449542630395545
Receivables turnover: 126.74340445056207
Capitalized R&D asset: 18655147.05882353
ROCI (R&D-adjusted, %): 12.721568827961374
FCF margin (%): 36.35489058771038
Rule of 40 score: 36.35489058771038
Financial ratios for CGG.TO — annual report dated 2023-12-31
Total revenue: 348056060.60606056
Gross profit: 55083333.33333333
Operating income: 19929545.454545453
Net income: -17400757.575757574
Capital expenditures: 46518939.39393939
Operating cash flow: 1192424.2424242424
Depreciation & amortization: 92174242.42424242
Net tangible assets: 1293074242.4242423
Owner earnings: 28254545.454545453
Capex to operating income (%): 233.41696126506255
Buffett classification: The Gruesome
Stock price: 4.090909090909091
Shares outstanding: 396413753
Book value: 1308894696.9696968
P/B ratio: 1.2389786815269188
Market cap (USD): 1621692625.909091
Debt to equity: 0.4444815513436331
Current ratio: 1.5590865187852991
Quick ratio: 0.6045051976753703
Interest coverage ratio: 1.2415404219170323
COGS to revenue (%): 84.17400540665254
R&D to revenue (%): 1.8951579552231659
SG&A to revenue (%): 6.8116421509944844
Free cash flow (dilution-adjusted): -45376515.15151515
Buyback yield (%): 0
Retained earnings: 288162878.78787875
Inventory turnover: 1.3264277849996398
Receivables turnover: 23.728643735151323
Capitalized R&D asset: 19095160.650623888
ROCI (R&D-adjusted, %): 0.9357382526148319
Rosenberg metric: -12.301512225244046
FCF margin (%): -13.037128292638334
Revenue growth (%): -57.16035378789045
Rule of 40 score: -70.19748208052879
Financial ratios for CGG.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.444444444444444
Shares outstanding: 396413753
Market cap (USD): 1761838902.2222219
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGG.TO — annual report dated 2024-12-31
Total revenue: 529123076.9230769
Gross profit: 125841958.04195805
Operating income: 84183916.08391608
Net income: 45662937.062937066
Capital expenditures: 59185314.685314685
Operating cash flow: 214612587.41258743
Depreciation & amortization: 102074825.17482518
Net tangible assets: 1232474125.874126
Owner earnings: 88552447.55244756
Return on net tangible assets (%): 7.184933597664145
Capex to operating income (%): 70.30477725260211
Buffett classification: The Good
Stock price: 5.0419580419580425
P/E ratio: 43.77076111259151
Shares outstanding: 396413753
Book value: 1249095104.895105
P/B ratio: 1.6001195601907061
Market cap (USD): 1998701509.881119
Debt to equity: 0.4160231238726104
Current ratio: 1.9587797540507732
Quick ratio: 1.107267054884092
Effective tax rate (%): 29.952799828363013
Interest coverage ratio: 6.148577557587211
COGS to revenue (%): 76.21688345672878
R&D to revenue (%): 2.077854108790637
SG&A to revenue (%): 5.365785321008768
Free cash flow (dilution-adjusted): 155427272.72727272
Buyback yield (%): 0
Retained earnings: 303244755.24475527
Inventory turnover: 1.985819803378041
Receivables turnover: 102.3462735019613
Capitalized R&D asset: 21570066.24502948
ROCI (R&D-adjusted, %): 4.5254337309471
Rosenberg metric: 10.727160286595225
FCF margin (%): 29.374502739722402
Revenue growth (%): 52.02237133918292
Rule of 40 score: 81.39687407890531
Financial ratios for CGG.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.0419580419580425
Shares outstanding: 396413753
Market cap (USD): 1998701509.881119
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGG.TO — quarterly report dated 2025-03-31
Total revenue: 190976223.77622378
Gross profit: 81140559.44055945
Operating income: 70582517.48251748
Net income: 60125174.82517483
Capital expenditures: 17286713.286713287
Operating cash flow: 100370629.37062937
Net tangible assets: 1296013986.013986
Owner earnings: 42838461.53846154
Return on net tangible assets (%): 3.305401176280149
Capex to operating income (%): 24.49149435764319
Buffett classification: The Great
Stock price: 6.769230769230769
P/E ratio: 11.157623166819803
Shares outstanding: 396413753
Book value: 1313095104.895105
P/B ratio: 2.0435809745617837
Market cap (USD): 2683416174.1538463
Debt to equity: 0.3962388548701994
Current ratio: 2.2240468636706248
Quick ratio: 1.4229967872936176
Effective tax rate (%): 10.2234520204657
Interest coverage ratio: 23.374942102825383
COGS to revenue (%): 57.51274277177257
R&D to revenue (%): 1.2069016023669334
SG&A to revenue (%): 3.885080704221226
Free cash flow (dilution-adjusted): 83083916.08391608
Buyback yield (%): 0
Retained earnings: 362694405.5944056
Inventory turnover: 0.5619338265809923
Receivables turnover: 37.009892939422684
Capitalized R&D asset: 2304895.104895105
ROCI (R&D-adjusted, %): 3.835268564002193
FCF margin (%): 43.50484811201922
Rule of 40 score: 43.50484811201922
Financial ratios for CGG.TO — quarterly report dated 2025-06-30
Total revenue: 224283941.6058394
Gross profit: 115204379.56204379
Operating income: 102993430.65693429
Net income: 84921897.81021897
Capital expenditures: 16235766.423357664
Operating cash flow: 139648175.18248174
Net tangible assets: 1427967883.2116787
Owner earnings: 68686131.38686131
Return on net tangible assets (%): 4.810061360230146
Capex to operating income (%): 15.763885443760145
Buffett classification: The Great
Stock price: 8.839416058394159
P/E ratio: 24.158130394294133
Shares outstanding: 396413753
Book value: 1445894160.5839415
P/B ratio: 2.4234596069060386
Market cap (USD): 3504066094.0364957
Debt to equity: 0.35998536000504827
Current ratio: 1.700663313796927
Quick ratio: 1.1171728971962616
Effective tax rate (%): 16.45146927871772
Interest coverage ratio: 36.198306824012306
COGS to revenue (%): 48.63458402897787
R&D to revenue (%): 1.7105532936937993
SG&A to revenue (%): 3.4175266623056673
Free cash flow (dilution-adjusted): 121441605.83941604
Buyback yield (%): 0
Retained earnings: 437720437.95620435
Inventory turnover: 0.5071126555045031
Receivables turnover: 25.450923548413815
Capitalized R&D asset: 5380776.070644684
ROCI (R&D-adjusted, %): 5.497122044320701
Rosenberg metric: 14.778902540571178
FCF margin (%): 54.146366864213434
Revenue growth (%): 17.44076679861673
Rule of 40 score: 71.58713366283015
Financial ratios for CGG.TO — quarterly report dated 2025-09-30
Total revenue: 248220143.8848921
Gross profit: 140582014.38848922
Operating income: 124373381.29496403
Net income: 102369784.17266187
Capital expenditures: 6123021.582733814
Operating cash flow: 168858992.8057554
Net tangible assets: 1567704316.5467627
Owner earnings: 96246762.58992806
Return on net tangible assets (%): 6.139344108073528
Capex to operating income (%): 4.923096501020946
Buffett classification: The Great
Stock price: 17.561151079136692
P/E ratio: 28.136651221308043
Shares outstanding: 396413753
Book value: 1586206474.820144
P/B ratio: 4.388761436035571
Market cap (USD): 6961481806.280577
Debt to equity: 0.26545710842619397
Current ratio: 2.029854000076196
Quick ratio: 1.408177519652208
Effective tax rate (%): 7.270120560443141
Interest coverage ratio: 42.972657220979364
COGS to revenue (%): 43.36397836684772
R&D to revenue (%): 2.2746111887220097
SG&A to revenue (%): 3.640305368291085
Free cash flow (dilution-adjusted): 159749640.2877698
Buyback yield (%): 0
Retained earnings: 536377697.84172666
Inventory turnover: 0.5093847562823224
Receivables turnover: 43.12285964254468
Capitalized R&D asset: 8977111.104827536
ROCI (R&D-adjusted, %): 6.233387918969776
Rosenberg metric: 6.614794465797231
FCF margin (%): 64.35804837896274
Revenue growth (%): 10.67227644907303
Rule of 40 score: 75.03032482803576
Financial ratios for CGG.TO — annual report dated 2025-12-31
Total revenue: 956295620.4379561
Gross profit: 494062043.7956204
Operating income: 424451824.81751823
Net income: 344755474.4525547
Capital expenditures: 51657664.23357664
Operating cash flow: 518236496.3503649
Depreciation & amortization: 121167153.28467153
Net tangible assets: 1685393430.6569343
Owner earnings: 414264963.5036496
Return on net tangible assets (%): 24.57971865608714
Capex to operating income (%): 12.170442253555036
Buffett classification: The Great
Stock price: 19.744525547445253
P/E ratio: 22.703052028095655
Shares outstanding: 396413753
Book value: 1705858394.160584
P/B ratio: 4.588306684927766
Market cap (USD): 7827001473.467153
Debt to equity: 0.23426525849519858
Current ratio: 2.249959592171872
Quick ratio: 1.6152097220156933
Effective tax rate (%): 15.682879151678522
Interest coverage ratio: 36.214672728405056
COGS to revenue (%): 48.33584581623891
R&D to revenue (%): 2.503501574277264
SG&A to revenue (%): 4.0307604236237
Free cash flow (dilution-adjusted): 466460583.9416058
Buyback yield (%): 0
Retained earnings: 593500000
Inventory turnover: 2.15002580329739
Receivables turnover: 158.880063060878
Capitalized R&D asset: 33483877.660660505
ROCI (R&D-adjusted, %): 20.260488621226838
Rosenberg metric: 33.49158647931161
FCF margin (%): 48.777864707566074
Revenue growth (%): 80.73217029182435
Rule of 40 score: 129.51003499939043
Financial ratios for CGG.TO — quarterly report dated 2025-12-31
Total revenue: 280827737.22627735
Gross profit: 151529197.08029196
Operating income: 121595620.4379562
Net income: 93210948.90510948
Capital expenditures: 6283211.678832117
Operating cash flow: 102497810.21897809
Net tangible assets: 1685393430.6569343
Owner earnings: 86927737.22627737
Return on net tangible assets (%): 5.157711881693676
Capex to operating income (%): 5.167300973671257
Buffett classification: The Great
Stock price: 19.744525547445253
P/E ratio: 22.978163679503282
Shares outstanding: 396413753
Book value: 1705858394.160584
P/B ratio: 4.588306684927766
Market cap (USD): 7827001473.467153
Debt to equity: 0.23426525849519858
Current ratio: 2.249959592171872
Quick ratio: 1.6152097220156933
Effective tax rate (%): 25.623642198575364
Interest coverage ratio: 43.631744368779465
COGS to revenue (%): 46.04194066549876
R&D to revenue (%): 4.262425467985674
SG&A to revenue (%): 4.974085991880104
Free cash flow (dilution-adjusted): 96214598.54014598
Buyback yield (%): 0
Retained earnings: 593500000
Inventory turnover: 0.6014171442540132
Receivables turnover: 46.65704584040747
Capitalized R&D asset: 17018965.70918448
ROCI (R&D-adjusted, %): 5.939584583847214
Rosenberg metric: 1.938912326912055
FCF margin (%): 34.261073884813925
Revenue growth (%): 13.136562098081155
Rule of 40 score: 47.39763598289508
Financial ratios for CML.L — annual report dated 2022-03-31
Total revenue: 22321052.63157895
Gross profit: 16835526.315789472
Operating income: 1702631.5789473683
Net income: 1628947.3684210526
Capital expenditures: 1453947.3684210526
Operating cash flow: 5151315.7894736845
Depreciation & amortization: 3188157.8947368423
Net tangible assets: 39481578.94736842
Owner earnings: 3363157.8947368423
Return on net tangible assets (%): 8.518296340731855
Capex to operating income (%): 85.39412673879444
Buffett classification: The Gruesome
Stock price: 0.03921052631578947
P/E ratio: 0.4010002578352181
Shares outstanding: 16659004
Book value: 65596052.631578945
P/B ratio: 0.009958043030509699
Market cap (USD): 653208.3147368421
Debt to equity: 0.009387599542655408
Current ratio: 10.288157470151662
Quick ratio: 9.559535333978703
Effective tax rate (%): 28.727691421991935
Interest coverage ratio: 39.21212121212121
COGS to revenue (%): 24.575571799103983
R&D to revenue (%): 7.43338835180382
SG&A to revenue (%): 45.97382692761142
Free cash flow (dilution-adjusted): -1078947.3684210526
Buyback yield (%): 0
Retained earnings: 51761842.10526316
Inventory turnover: 1.8463241806908768
Receivables turnover: 13.099613899613901
Capitalized R&D asset: 1659210.5263157894
ROCI (R&D-adjusted, %): 3.7129157752537987
FCF margin (%): -4.8337656213157265
Rule of 40 score: -4.8337656213157265
Financial ratios for CML.L — annual report dated 2023-03-31
Total revenue: 25485185.185185183
Gross profit: 19272839.50617284
Operating income: 4227160.49382716
Net income: 5938271.604938271
Capital expenditures: 1935802.4691358022
Operating cash flow: 6681481.481481481
Depreciation & amortization: 3354320.987654321
Net tangible assets: 35234567.90123457
Owner earnings: 7356790.123456791
Return on net tangible assets (%): 20.879467414155574
Capex to operating income (%): 45.79439252336448
Buffett classification: The Good
Stock price: 0.05839506172839506
P/E ratio: 0.1638193116839917
Shares outstanding: 16659004
Book value: 62659259.259259254
P/B ratio: 0.015525296315561337
Market cap (USD): 972803.5669135802
Debt to equity: 0.020727430350317218
Current ratio: 9.391095066185319
Quick ratio: 8.661552346570398
Effective tax rate (%): 7.7837423312883445
Interest coverage ratio: 72.85106382978724
COGS to revenue (%): 24.37630189410454
R&D to revenue (%): 3.2747178220219926
SG&A to revenue (%): 42.61977425761759
Free cash flow (dilution-adjusted): -379012.34567901236
Buyback yield (%): 604.9715878260139
Retained earnings: 46812345.67901234
Inventory turnover: 2.0750515463917525
Receivables turnover: 14.692526690391459
Capitalized R&D asset: 1946238.9538661467
ROCI (R&D-adjusted, %): 5.83568071097595
Rosenberg metric: 1.468959575488786
FCF margin (%): -1.4871869398827693
Revenue growth (%): 14.175552586304752
Rule of 40 score: 12.688365646421982
Financial ratios for CML.L — annual report dated 2024-03-31
Total revenue: 28978481.012658227
Gross profit: 20518987.34177215
Operating income: 2698734.1772151897
Net income: 2607594.9367088606
Capital expenditures: 1929113.9240506329
Operating cash flow: 6384810.126582278
Depreciation & amortization: 4410126.582278481
Net tangible assets: 22945569.620253164
Owner earnings: 5088607.594936708
Return on net tangible assets (%): 22.176863242676667
Capex to operating income (%): 71.48217636022515
Buffett classification: The Good
Stock price: 0.03632911392405063
P/E ratio: 0.23209389067961167
Shares outstanding: 16659004
Book value: 64653164.55696203
P/B ratio: 0.009360823376928498
Market cap (USD): 605206.8541772151
Debt to equity: 0.01675933902419923
Current ratio: 3.626646593902898
Quick ratio: 3.165976665412119
Effective tax rate (%): 18.091451292246518
Interest coverage ratio: 57.621621621621614
COGS to revenue (%): 29.192329533045037
R&D to revenue (%): 4.197789717380859
SG&A to revenue (%): 42.92578517450749
Free cash flow (dilution-adjusted): -337974.68354430376
Buyback yield (%): 366.0219407840803
Retained earnings: 47779746.835443035
Inventory turnover: 1.8199891067538123
Receivables turnover: 8.648658859085758
Capitalized R&D asset: 2323155.6637139027
ROCI (R&D-adjusted, %): 3.359896211492329
Rosenberg metric: 1.4931653059695884
FCF margin (%): -1.1662953741318305
Revenue growth (%): 13.707162816708648
Rule of 40 score: 12.540867442576817
Financial ratios for CML.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 22246666.666666668
Buffett classification: The Gruesome
Stock price: 0.03626666666666667
Shares outstanding: 16659004
Book value: 66002666.66666667
P/B ratio: 0.009153668716415498
Market cap (USD): 604166.5450666667
Debt to equity: 0.048240475132317884
Current ratio: 3.7991685779816513
Quick ratio: 3.1156823394495414
Buyback yield (%): 0
Retained earnings: 49917333.333333336
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CML.L — annual report dated 2025-03-31
Total revenue: 29738961.038961038
Gross profit: 20635064.935064934
Operating income: 572727.2727272727
Net income: -23376.623376623374
Capital expenditures: 772727.2727272727
Operating cash flow: 4015584.4155844157
Depreciation & amortization: 5722077.922077922
Net tangible assets: 21733766.23376623
Owner earnings: 4925974.025974026
Capex to operating income (%): 134.92063492063494
Buffett classification: The Gruesome
Stock price: 0.026883116883116884
Shares outstanding: 16659004
Book value: 63644155.84415585
P/B ratio: 0.007036717601926294
Market cap (USD): 447845.9516883117
Debt to equity: 0.04607599069501693
Current ratio: 3.9384024858343993
Quick ratio: 2.9033083531347104
Interest coverage ratio: 4.160377358490566
COGS to revenue (%): 30.612690510502645
R&D to revenue (%): 5.611598759771169
SG&A to revenue (%): 41.792218000786065
Free cash flow (dilution-adjusted): -2644155.844155844
Buyback yield (%): 260.11959258388634
Retained earnings: 47392207.79220779
Inventory turnover: 1.2378597916298781
Receivables turnover: 14.0830258302583
Capitalized R&D asset: 2759263.892694273
ROCI (R&D-adjusted, %): 1.2888187097118617
Rosenberg metric: 0.09542278741030105
FCF margin (%): -8.89121795711603
Revenue growth (%): 2.6242922324694034
Rule of 40 score: -6.266925724646627
Financial ratios for CML.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 21733766.23376623
Buffett classification: The Gruesome
Stock price: 0.026883116883116884
Shares outstanding: 16659004
Book value: 63644155.84415585
P/B ratio: 0.007036717601926294
Market cap (USD): 447845.9516883117
Debt to equity: 0.04607599069501693
Current ratio: 3.9384024858343993
Quick ratio: 2.9033083531347104
Buyback yield (%): 0
Retained earnings: 47392207.79220779
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CML.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 22750000
Buffett classification: The Gruesome
Stock price: 0.03608108108108108
Shares outstanding: 16659004
Book value: 66694594.5945946
P/B ratio: 0.009012347667868865
Market cap (USD): 601074.874054054
Debt to equity: 0.0403817319771447
Current ratio: 3.327059504850152
Quick ratio: 2.565078905458231
Buyback yield (%): 0
Retained earnings: 50582432.432432435
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DXRX.L — annual report dated 2021-12-31
Total revenue: 18841891.891891893
Gross profit: 16529729.72972973
Operating income: 743243.2432432432
Net income: 758108.1081081082
Capital expenditures: 763513.5135135135
Operating cash flow: 770270.2702702703
Depreciation & amortization: 2431081.081081081
Net tangible assets: 37605405.4054054
Owner earnings: 2425675.6756756757
Return on net tangible assets (%): 6.450337789276987
Capex to operating income (%): 102.72727272727273
Buffett classification: The Gruesome
Stock price: 0.013783783783783785
P/E ratio: 1.5387172727272729
Shares outstanding: 84629450
Book value: 54931081.08108108
P/B ratio: 0.021235956358089992
Market cap (USD): 1166514.0405405406
Debt to equity: 0.03840192870673326
Current ratio: 11.413059984813971
Quick ratio: 11.413059984813971
Effective tax rate (%): -21.428571428571427
Interest coverage ratio: 6.249999999999999
COGS to revenue (%): 12.271390661980924
SG&A to revenue (%): 85.1825288675321
Free cash flow (dilution-adjusted): -7302702.702702703
Buyback yield (%): 19.114469712653566
Retained earnings: 5518918.918918919
Receivables turnover: 2.3242207034505755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2978125958611577
FCF margin (%): -38.75779961270889
Rule of 40 score: -38.75779961270889
Financial ratios for DXRX.L — annual report dated 2022-12-31
Total revenue: 23498795.180722892
Gross profit: 20169879.51807229
Operating income: 692771.0843373494
Net income: 872289.156626506
Capital expenditures: 224096.3855421687
Operating cash flow: 6139759.036144579
Depreciation & amortization: 3624096.3855421687
Net tangible assets: 32881927.710843377
Owner earnings: 4272289.156626507
Return on net tangible assets (%): 12.992818408324785
Capex to operating income (%): 32.34782608695652
Buffett classification: The Good
Stock price: 0.009156626506024097
P/E ratio: 0.8883754419889504
Shares outstanding: 84629450
Book value: 51221686.746987954
P/B ratio: 0.015128753351837044
Market cap (USD): 774920.265060241
Debt to equity: 0.031260290727760265
Current ratio: 8.23454157782516
Quick ratio: 8.23454157782516
Effective tax rate (%): -28.368794326241137
Interest coverage ratio: 4.791666666666667
COGS to revenue (%): 14.166324856439704
SG&A to revenue (%): 83.47005742411814
Free cash flow (dilution-adjusted): -373493.97590361454
Buyback yield (%): 15.236701694392748
Retained earnings: 6438554.21686747
Receivables turnover: 3.3674033149171274
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2920186949487686
FCF margin (%): -1.589417555373257
Revenue growth (%): 24.715688400881728
Rule of 40 score: 23.126270845508472
Financial ratios for DXRX.L — annual report dated 2023-12-31
Total revenue: 29998734.17721519
Gross profit: 24944303.797468353
Operating income: -3820253.164556962
Net income: -2210126.5822784808
Capital expenditures: 158227.84810126582
Operating cash flow: 1659493.6708860758
Depreciation & amortization: 6041772.151898734
Net tangible assets: 32308860.759493668
Owner earnings: 3673417.721518988
Buffett classification: The Gruesome
Stock price: 0.0110126582278481
Shares outstanding: 84629450
Book value: 51627848.10126582
P/B ratio: 0.018052180037267686
Market cap (USD): 931995.2088607594
Debt to equity: 0.02954445152748492
Current ratio: 6.397444672598676
Quick ratio: 6.397444672598676
Interest coverage ratio: -45.72727272727273
COGS to revenue (%): 16.848812186168193
SG&A to revenue (%): 96.1390775982109
Free cash flow (dilution-adjusted): -5049367.088607594
Buyback yield (%): 6.655111084907178
Retained earnings: 5117721.518987342
Receivables turnover: 3.1896366083445495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.192392936297991
FCF margin (%): -16.831933836870753
Revenue growth (%): 27.660733014195067
Rule of 40 score: 10.828799177324314
Financial ratios for DXRX.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 30555000
Buffett classification: The Gruesome
Stock price: 0.01575
Shares outstanding: 84629450
Book value: 49821250
P/B ratio: 0.02675392202122588
Market cap (USD): 1332913.8375
Debt to equity: 0.026595077401711117
Current ratio: 3.802833226014166
Quick ratio: 3.802833226014166
Buyback yield (%): 0
Retained earnings: 50781250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DXRX.L — annual report dated 2024-12-31
Total revenue: 40197500
Gross profit: 35337500
Operating income: -3068750
Net income: -2128750
Capital expenditures: 125000
Operating cash flow: 813750
Depreciation & amortization: 5783750
Net tangible assets: 30555000
Owner earnings: 3530000
Buffett classification: The Gruesome
Stock price: 0.01575
Shares outstanding: 84629450
Book value: 49821250
P/B ratio: 0.02675392202122588
Market cap (USD): 1332913.8375
Debt to equity: 0.026595077401711117
Current ratio: 3.802833226014166
Quick ratio: 3.802833226014166
Interest coverage ratio: -45.46296296296296
COGS to revenue (%): 12.090304123390757
SG&A to revenue (%): 95.59674109086386
Free cash flow (dilution-adjusted): -6251250
Buyback yield (%): 0
Retained earnings: 50781250
Receivables turnover: 3.0169809550614506
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.009056419042957
FCF margin (%): -15.5513402574787
Revenue growth (%): 33.99732056204904
Rule of 40 score: 18.44598030457034
Financial ratios for DXRX.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 29971232.87671233
Buffett classification: The Gruesome
Stock price: 0.016164383561643837
Shares outstanding: 84629450
Book value: 51015068.49315069
P/B ratio: 0.026815271072205365
Market cap (USD): 1367982.890410959
Debt to equity: 0.03045031014204774
Current ratio: 3.9560155239327295
Quick ratio: 3.9560155239327295
Buyback yield (%): 0
Retained earnings: 52943835.61643836
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECAT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.54
Shares outstanding: 99468307
Market cap (USD): 948927648.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECAT — annual report dated 2022-12-31
Total revenue: -311169313
Net income: -312896552
Capital expenditures: 0
Operating cash flow: 185867591
Net tangible assets: 1701873225
Owner earnings: -312896552
Return on net tangible assets (%): -18.385420688429953
Buffett classification: The Gruesome
Stock price: 7.45
Shares outstanding: 99468307
Book value: 1701873225
P/B ratio: 0.4354254337305295
Market cap (USD): 741038887.15
Debt to equity: 0
Free cash flow (dilution-adjusted): 185867591
Buyback yield (%): 6.148034710461551
Retained earnings: -300196864
Receivables turnover: -2.4832871382009762
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECAT — annual report dated 2023-12-31
Total revenue: 297441776
Net income: 294920943
Capital expenditures: 0
Operating cash flow: 165606150
Net tangible assets: 1838694945
Owner earnings: 294920943
Return on net tangible assets (%): 16.03968857378895
Buffett classification: The Gruesome
Stock price: 9.86
P/E ratio: 3.325492916995047
Shares outstanding: 99468307
Book value: 1838694945
P/B ratio: 0.5333987074294153
Market cap (USD): 980757507.02
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.6601994603474933
Free cash flow (dilution-adjusted): 165606150
Buyback yield (%): 0.9143423257852393
Retained earnings: -41217004
Receivables turnover: 15.393441576017343
Capitalized R&D asset: 0
FCF margin (%): 55.67682933684473
Rule of 40 score: 55.67682933684473
Financial ratios for ECAT — annual report dated 2024-12-31
Total revenue: 244601144
Net income: 240595420
Capital expenditures: 0
Operating cash flow: 338434040
Net tangible assets: 1744896018
Owner earnings: 240595420
Return on net tangible assets (%): 13.788524789905274
Buffett classification: The Gruesome
Stock price: 11.83
P/E ratio: 4.890824903524764
Shares outstanding: 99468307
Book value: 1744896018
P/B ratio: 0.6743726042533728
Market cap (USD): 1176710071.81
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 1.2549176793711152
Free cash flow (dilution-adjusted): 338434040
Buyback yield (%): 3.9077889364258627
Retained earnings: 157842646
Receivables turnover: 32.47903996337295
Capitalized R&D asset: 0
FCF margin (%): 138.36159327202492
Revenue growth (%): -17.76503378597363
Rule of 40 score: 120.59655948605129
Financial ratios for ECAT — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1744896018
Buffett classification: The Gruesome
Stock price: 11.83
Shares outstanding: 99468307
Book value: 1744896018
P/B ratio: 0.6743726042533728
Market cap (USD): 1176710071.81
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 157842646
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECAT — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1656681730
Buffett classification: The Gruesome
Stock price: 12.97
Shares outstanding: 99468307
Book value: 1656681730
P/B ratio: 0.7787276930916599
Market cap (USD): 1290103941.79
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 69628358
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.74
Shares outstanding: 2183696415
Market cap (USD): 64943131382.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENB — annual report dated 2022-12-31
Total revenue: 39197794117.64706
Gross profit: 12061029411.764706
Operating income: 6017647058.823529
Net income: 2208088235.2941175
Capital expenditures: 3544852941.1764703
Operating cash flow: 8257352941.17647
Depreciation & amortization: 3174264705.882353
Net tangible assets: 17227205882.35294
Owner earnings: 1837499999.9999995
Return on net tangible assets (%): 10.66626829997012
Capex to operating income (%): 58.90762463343108
Buffett classification: The Good
Stock price: 31.66
P/E ratio: 31.310265320847158
Shares outstanding: 2183696415
Book value: 46616176470.58824
P/B ratio: 1.4830866393025646
Market cap (USD): 69135828498.9
Debt to equity: 1.2773273604845576
Current ratio: 0.5983449091177775
Quick ratio: 0.4872666371114724
Effective tax rate (%): 35.31483927785117
Interest coverage ratio: 2.5384615384615388
COGS to revenue (%): 69.23033634095556
SG&A to revenue (%): -0.44832955035735056
Free cash flow (dilution-adjusted): 4712500000
Buyback yield (%): 1.2273367227792846
Retained earnings: -11386764705.882353
Inventory turnover: 16.36629711751663
Receivables turnover: 8.807037832479761
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.137250717168737
FCF margin (%): 12.022360201842092
Rule of 40 score: 12.022360201842092
Financial ratios for ENB — annual report dated 2023-12-31
Total revenue: 33067424242.42424
Gross profit: 13386363636.363636
Operating income: 6871212121.212121
Net income: 4690151515.151515
Capital expenditures: 3693939393.939394
Operating cash flow: 10758333333.333332
Depreciation & amortization: 3494696969.6969695
Net tangible assets: 19749242424.242424
Owner earnings: 4490909090.90909
Return on net tangible assets (%): 22.739652460777165
Capex to operating income (%): 53.759647188533634
Buffett classification: The Good
Stock price: 31.3
P/E ratio: 14.573025534185108
Shares outstanding: 2183696415
Book value: 48850757575.75757
P/B ratio: 1.3991532819834687
Market cap (USD): 68349697789.5
Debt to equity: 1.2592311151776439
Current ratio: 0.8258675078864353
Quick ratio: 0.7410381416690565
Effective tax rate (%): 23.11207005965224
Interest coverage ratio: 2.3515685766139485
COGS to revenue (%): 59.51797292034181
SG&A to revenue (%): -0.3092854360924649
Free cash flow (dilution-adjusted): 7064393939.393939
Buyback yield (%): 0.13854775186952942
Retained earnings: -12965909090.90909
Inventory turnover: 17.56524678837052
Receivables turnover: 9.014663362247004
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.568448324553971
FCF margin (%): 21.363605122683225
Revenue growth (%): -15.639578739618134
Rule of 40 score: 5.724026383065091
Financial ratios for ENB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.28
Shares outstanding: 2183696415
Market cap (USD): 81408202351.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENB — annual report dated 2024-12-31
Total revenue: 37393706293.7063
Gross profit: 13472727272.727274
Operating income: 6880419580.41958
Net income: 3937762237.762238
Capital expenditures: 4846153846.153847
Operating cash flow: 8811188811.188812
Depreciation & amortization: 3613286713.2867136
Net tangible assets: 17281818181.818184
Owner earnings: 2704895104.8951054
Return on net tangible assets (%): 15.651681301339377
Capex to operating income (%): 70.43398719382051
Buffett classification: The Good
Stock price: 39.55
P/E ratio: 21.932556614268776
Shares outstanding: 2183696415
Book value: 48176923076.923096
P/B ratio: 1.792667270912102
Market cap (USD): 86365193213.25
Debt to equity: 1.478292424484345
Current ratio: 0.5527885099949605
Quick ratio: 0.4902990089030741
Effective tax rate (%): 22.852445540485
Interest coverage ratio: 2.2356282663031126
COGS to revenue (%): 63.97060198604903
Free cash flow (dilution-adjusted): 3965034965.034965
Buyback yield (%): 0
Retained earnings: -14018181818.181818
Inventory turnover: 22.988575268817204
Receivables turnover: 7.240758293838863
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.041478574100358
FCF margin (%): 10.603482131168999
Revenue growth (%): 13.08321452425558
Rule of 40 score: 23.686696655424576
Financial ratios for ENB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.55
Shares outstanding: 2183696415
Market cap (USD): 86365193213.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENB — quarterly report dated 2025-03-31
Total revenue: 12938461538.461538
Gross profit: 4295804195.804196
Operating income: 2567832167.832168
Net income: 1741258741.2587414
Capital expenditures: 1246853146.8531468
Operating cash flow: 2134965034.965035
Depreciation & amortization: 984615384.6153847
Net tangible assets: 18981818181.818184
Owner earnings: 1479020979.0209792
Return on net tangible assets (%): 7.791777188328912
Capex to operating income (%): 48.55664488017428
Buffett classification: The Good
Stock price: 41.92
P/E ratio: 13.142870664159036
Shares outstanding: 2183696415
Book value: 49846153846.15384
P/B ratio: 1.8364617258000004
Market cap (USD): 91540553716.8
Debt to equity: 1.4465909090909095
Current ratio: 0.7297413330471182
Quick ratio: 0.6638402919394655
Effective tax rate (%): 21.870097270160027
Interest coverage ratio: 2.7526236881559223
COGS to revenue (%): 66.79818398011025
Free cash flow (dilution-adjusted): 888111888.1118882
Buyback yield (%): 0
Retained earnings: -12437062937.062937
Inventory turnover: 10.064332247557003
Receivables turnover: 2.397563820137359
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8231377630814605
FCF margin (%): 6.864122797535402
Rule of 40 score: 6.864122797535402
Financial ratios for ENB — quarterly report dated 2025-06-30
Total revenue: 10858394160.58394
Gross profit: 3597810218.9781017
Operating income: 1911678832.1167881
Net income: 1694160583.9416058
Capital expenditures: 1433576642.3357663
Operating cash flow: 2363503649.6350365
Depreciation & amortization: 1015328467.1532845
Net tangible assets: 18985401459.85401
Owner earnings: 1275912408.7591243
Return on net tangible assets (%): 6.720492118415996
Capex to operating income (%): 74.99045437189767
Buffett classification: The Good
Stock price: 43.53
P/E ratio: 27.669491245994113
Shares outstanding: 2183696415
Book value: 49896350364.963486
P/B ratio: 1.9050753061028927
Market cap (USD): 95056304944.95
Debt to equity: 1.4782907633342115
Current ratio: 0.7477544404673464
Quick ratio: 0.6522590666576619
Effective tax rate (%): 22.29661868095079
Interest coverage ratio: 2.217612193056732
COGS to revenue (%): 66.8660930357623
Free cash flow (dilution-adjusted): 929927007.29927
Buyback yield (%): 0
Retained earnings: -12892700729.927006
Inventory turnover: 7.034653465346534
Receivables turnover: 2.691027496382055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3308941230276699
FCF margin (%): 8.564130142511427
Revenue growth (%): -16.07662063757953
Rule of 40 score: -7.5124904950681035
Financial ratios for ENB — quarterly report dated 2025-09-30
Total revenue: 10531654676.258993
Gross profit: 3420143884.8920865
Operating income: 1633812949.6402879
Net income: 609352517.9856116
Capital expenditures: 1735251798.5611513
Operating cash flow: 2063309352.5179858
Depreciation & amortization: 1005755395.6834533
Net tangible assets: 18154676258.992805
Owner earnings: -120143884.89208627
Return on net tangible assets (%): -0.6617792748167224
Capex to operating income (%): 106.20871862615589
Buffett classification: The Gruesome
Stock price: 49.17
P/E ratio: 26.54596028857234
Shares outstanding: 2183696415
Book value: 48975539568.34534
P/B ratio: 2.192366917687797
Market cap (USD): 107372352725.55
Debt to equity: 1.5234296962218694
Current ratio: 0.8031380892227911
Quick ratio: 0.6765507612525763
Effective tax rate (%): 27.171109200343942
Interest coverage ratio: 1.799524564183835
COGS to revenue (%): 67.52510417378237
Free cash flow (dilution-adjusted): 328057553.95683455
Buyback yield (%): 0
Retained earnings: -13715107913.669065
Inventory turnover: 5.191701680672269
Receivables turnover: 2.4624053826745165
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1246360160846225
FCF margin (%): 3.114966869321675
Revenue growth (%): -3.0090958155766194
Rule of 40 score: 0.10587105374505557
Financial ratios for ENB — annual report dated 2025-12-31
Total revenue: 47586861313.86861
Gross profit: 15691240875.912407
Operating income: 8414598540.145985
Net income: 5685401459.854014
Capital expenditures: 6689781021.89781
Operating cash flow: 8956204379.562042
Depreciation & amortization: 4132116788.3211675
Net tangible assets: 16818978102.18978
Owner earnings: 3127737226.2773724
Return on net tangible assets (%): 18.596476000347195
Capex to operating income (%): 79.50208188757809
Buffett classification: The Gruesome
Stock price: 46.6
P/E ratio: 17.89851669359738
Shares outstanding: 2183696415
Book value: 47582481751.8248
P/B ratio: 2.1386075125242385
Market cap (USD): 101760252939
Debt to equity: 1.6145916426336142
Current ratio: 0.6282136735859836
Quick ratio: 0.551037897543325
Effective tax rate (%): 20.463596446441336
Interest coverage ratio: 2.309294871794872
COGS to revenue (%): 67.0261066969353
Free cash flow (dilution-adjusted): 2266423357.664233
Buyback yield (%): 0
Retained earnings: -15535766423.357662
Inventory turnover: 26.95681677976558
Receivables turnover: 8.677492346599228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.837819224088601
FCF margin (%): 4.762708224683252
Revenue growth (%): 27.259012359194546
Rule of 40 score: 32.0217205838778